FDA issued a Warning Letter to Signature Formulations, LLC on 7/31/2018 as a result of this inspection.
483 Signature Formulations Nov 2017

483 Signature Formulations Nov 2017

Nicholas Hunt FDA$119.00 - Available Now

FDA investigators audited the Signature Formulations - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 09 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Nov 2017
  • Location: Phoenix, United States
  • FEI: 3011368010
Add To Cart